HCW Biologics Inc
HCWB
NASDAQ
Biotechnology
$2.68
USD
-0.25 (-8.38%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $4.67M
Volume 129.3K
Revenue
$6.59M
TTM
+356.2%
YoY
Gross Margin
99%
TTM
+314.9%
YoY
Net Income
$-2.29M
TTM
+90.7%
YoY
Operating Cash Flow
$-11.45M
TTM
+19.0%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 6.5 |
YoY Growth | -99.6% | -98.9% | -96.3% | -93.2% | +129080.7% |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 6.5 |
Selling, General & Administrative | 2.2 | 2.1 | 1.9 | 3.1 | 1.8 |
Other Operating Expenses | -1.7 | 0.1 | 0.0 | 0.0 | 0.2 |
Total Operating Expenses | 2.0 | 3.5 | 3.3 | 4.5 | 3.3 |
Operating Income | -2.0 | -3.5 | -3.3 | -4.5 | 3.2 |
EBITDA | -1.5 | -3.2 | -3.1 | -4.3 | 3.4 |
Other Income / Expense | 0.0 | 1.8 | -1.1 | 5.4 | 0.7 |
Total Other Income / Expense | -0.2 | 1.5 | -1.3 | 5.2 | 0.6 |
Income Before Income Taxes | -2.2 | -1.9 | -4.6 | 0.7 | 3.8 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 |
Net Income | -2.2 | -1.9 | -4.6 | 0.7 | 3.5 |
Consolidated Net Income / Loss | -2.2 | -1.9 | -4.6 | 0.7 | 3.5 |
Net Income Attributable to Common Shareholders | -2.2 | -12.1 | -4.6 | -3.5 | 2.0 |
Basic EPS | -$11.82 | -$40.74 | -$12.12 | -$6.43 | $2.22 |
Diluted EPS | -$11.82 | -$40.74 | -$12.12 | -$6.43 | $2.22 |
Basic Shares Outstanding | 0.2M | 0.3M | 0.4M | 0.5M | 0.9M |
Diluted Shares Outstanding | 0.2M | 0.3M | 0.4M | 0.5M | 0.9M |